PDCD1 and neoplasm: Our results show that combining JX-594 with a PD-1 inhibitor formed a tumor-suppressing TIME that increased the number of tumor-infiltrating CD8 + T cells, induced polarization from tumor-promoting M2 TAMs to tumor-suppressing M1 TAMs, and decreased tumor-promoting MDSCs.